Facts of Onglyza (saxagliptin) ?

  • Medicine Name: ONGLYZA
  • Generic Name: saxagliptin
  • Approval Date: Jan. 8, 2014
  • Company Name: Bristol-Myers Squibb Company
  • Available as (Form & Strength): Tablets: 5 mg and 10 mg.

What is indication and usage?

  • ONGLYZA is a dipeptidyl peptidase-4 inhibi tor indicated as an adjunct to diet and exercise to improve glycemic cont rol in adults with type 2 diabetes mellitus.

Limitation of Use

  • Should not be used for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.
  • Has not been studied in comb ination with insulin.

Quote From FDA

What is ONGLYZA?

ONGLYZA is a prescription medicine used with diet and exercise to control high blood sugar (hyperglycemia) in adults with type 2 diabetes.

ONGLYZA lowers blood sugar by helping the body in crease the level of insulin after meals.

ONGLYZA is unlikely to cause your blood sugar to be lowe red to a dangerous level (hypoglycemia) because it does not work well when your blood sugar is low.

ONGLYZA has not been studied in children younger than 18 years old.

Quote From FDA

Innovator Brands Available

Onglyza (saxagliptin) Bristol-Myers Squibb Company

ONGLYZA
Prescribing Information

Contact Details

IKRIS Pharma Network Pvt. Ltd.
905 , I - Thum Business Park,
Plot No. A-40, Unit No. 5, Tower A,
Sector-62, Noida – 201301 (India)

Phone No.- +91-120–2400370.
M: + 91 8130290915
E:info@ikrispharmanetwork.com

Query Form

What is the best price of Onglyza (saxagliptin) ?

Please contact +91 8130290915 for Onglyza (saxagliptin) price in India

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Where can I Buy Onglyza (saxagliptin) ?

IKRIS PHARMA NETWORK connects buyer with the supplier who can ship Onglyza (saxagliptin) (Cancer Treatment Medicines) to any country of the world as per the buyer's requirement and Government regulations of the country. Onglyza (saxagliptin) is manufactured by Bristol-Myers Squibb Company.

IKRIS PHARMA NETWORK provides options of choosing exporter and supplier of Cancer treatment Medicines We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Is Onglyza (saxagliptin) available in India?

Onglyza (saxagliptin) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IKRIS Pharma Network facilitates import of cancer medicines on the named patient supply. IKRIS Pharma Network is facilitator providing input

  • On availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
  • Medicine Price.
  • Finding Genuine and reliable source from Canada, Europe, USA and Australia
  • Ensuring 100% transparency.

Onglyza (saxagliptin) can be made available Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune and other cities in India"

IKRIS Pharma Network can facilitate the supply of Onglyza (saxagliptin) (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

How order will be confirmed ?

The order will be confirmed only after the receipt of

  1. Valid prescription of Clinician
  2. Import permit if applicable

Send your enquiry to find the

Cost of Onglyza (saxagliptin) in Australia, Brazil, China, Canada, Eqypt, Europe, France, Germany, Hongkong, India, Iran, Italy, Mexico, Pakistan, Poland, Spain, Singapore, Thailand, Russia, Romania, UK, Middle East, UAE, Ukraine.

Disclaimer

General disclaimer under Facts and usage:
Please note that all information in relation to this drug is of general nature and may not be applicable to your specific situation and circumstance. Any information available here is not a substitute for professional medical advice by a licensed practitioner. We will help you in importing this medicine only upon the valid prescription of a licensed medical practitioner and other documents as required by the laws of the jurisdiction in which you are present.

General disclaimer under where can I buy the medicine/is the medicine available in India:
Please note that Ikris Pharma Network is a consultancy company, which facilitates patients, hospitals, clinicians and researchers in accessing products, which are not available or approved in their home country. Ikris Pharma Network has no relation whatsoever with this medicine including but not limited to being its manufacturer, seller, reseller, distributor, agent or licensee. Ikris Pharma will not purchase this medicine but will only assist you in doing so against a valid prescription and other documents as required by the laws of the jurisdiction in which you are present. None of the trademarks and other intellectual property and proprietary marks of this medicine belong to or are claimed to belong to the Ikris Pharma Network.